ResMed

ResMed is a global leader in the development and manufacturing of cloud-connected medical devices designed to treat sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. By integrating digital health solutions with innovative hardware, the company empowers patients to manage their health from home while providing healthcare providers with actionable data to improve treatment outcomes. Their ecosystem of connected devices and software platforms has transformed the standard of care for millions of patients worldwide. With a strong focus on digital health, ResMed continues to lead the industry in remote patient monitoring and data-driven respiratory therapy. The company's commitment to innovation is reflected in its extensive portfolio of masks, ventilators, and software-as-a-service (SaaS) solutions that streamline clinical workflows and enhance the patient experience.

Mission: To improve the lives of millions of people with sleep-disordered breathing, COPD, and other chronic diseases by providing innovative, connected health solutions. Vision: To improve 250 million lives in out-of-hospital healthcare in 2025.

• Pioneer in cloud-connected CPAP technology for sleep apnea treatment.
• Global presence with operations in over 140 countries.
• Significant investment in digital health and AI-driven patient management software.
• Consistently recognized as a leader in respiratory care innovation.

Sources

• ResMed Official Website
• ResMed Investor Relations